Gene Therapy and Molecular Diagnosis
Fundamentals of Gene Therapy and Genomic Correction
Gene therapy serves as a sophisticated collection of biological methods that enable the correction of genetic defects diagnosed in individuals, specifically at the childhood or embryonic stages of development. The fundamental process involves the insertion of functional genes into a person's cells and tissues to treat a disease. Within this framework, the correction of a genetic defect requires the delivery of a normal, functional gene into the individual or embryo. This introduced gene is designed to take over the biological responsibilities of the non-functional gene and effectively compensate for its deficiencies.
Case Study: Adenosine Deaminase Deficiency Treatment in
The first instance of clinical gene therapy was administered in to a -year old girl suffering from adenosine deaminase (ADA) deficiency. The adenosine deaminase enzyme is vital for the proper functioning of the human immune system. This specific disorder results from the deletion of the gene responsible for the production of ADA. Genetic medicine offers several approaches to managing this condition; in some pediatric cases, ADA deficiency can be cured through bone marrow transplantation, while others receive enzyme replacement therapy. In enzyme replacement therapy, functional ADA is delivered directly to the patient via injection. However, a significant limitation of both bone marrow transplantation and enzyme replacement therapy is that they are not completely curative solutions.
Procedural Methodologies for Lymphocyte-Based Gene Modification
As a foundational step toward gene therapy for ADA deficiency, lymphocytes are extracted from the blood of the patient and grown in a culture outside the body. During this process, a functional ADA cDNA is introduced into these lymphocytes using a retroviral vector. Following this genetic engineering, the modified lymphocytes are returned to the patient. A practical challenge associated with this method is that lymphocytes are not immortal cells, meaning the patient requires periodic infusions of the genetically engineered lymphocytes to maintain therapeutic levels of the enzyme. However, a permanent cure could potentially be achieved if the gene isolated from marrow cells producing ADA is introduced into cells during early embryonic stages.
Limitations of Conventional Medical Diagnosis and the Role of Biotechnology
Effective disease treatment is heavily dependent on early diagnosis and a clear understanding of the pathophysiology of the condition. Conventional methods of diagnosis, which typically include serum and urine analysis, do not allow for early detection. Usually, the presence of a pathogen such as bacteria or viruses is only suspected once the pathogen has produced visible disease symptoms. By the time these symptoms manifest, the concentration of the pathogen in the body is already very high. To address these limitations, several biotechnological techniques serve the purpose of early diagnosis, including recombinant DNA technology, Polymerase Chain Reaction (PCR), and Enzyme Linked Immuno-sorbent Assay (ELISA).
Diagnostic Precision via Polymerase Chain Reaction (PCR)
Polymerase Chain Reaction (PCR) is a powerful diagnostic tool capable of detecting very low concentrations of bacteria or viruses even at a time when symptoms of the disease are not yet visible. This is achieved through the massive amplification of the pathogen's nucleic acid. In current medical practice, PCR is routinely utilized for the detection of HIV in suspected AIDS patients. Additionally, it is being used to detect specific mutations in genes among suspected cancer patients and serves as a critical technique for identifying many other genetic disorders.
Gene Mutation Detection using Radioactive Probes and Autoradiography
Another advanced molecular diagnostic technique involves the use of a single stranded DNA or RNA molecule tagged with a radioactive molecule, referred to as a probe. This probe is allowed to hybridize to its complementary DNA within a clone of cells, a process followed by detection via autoradiography. If a clone contains a mutated gene, it will not appear on the photographic film because the radioactive probe lacks complementarity with the mutated gene. This provides a clear visual method for identifying genetic abnormalities within a cellular population.
The Biological Foundation and Application of ELISA
The Enzyme Linked Immuno-sorbent Assay (ELISA) is a diagnostic technique based on the fundamental principle of antigen-antibody interaction. Infection by a specific pathogen can be detected using ELISA through two different mechanisms: the detection of the presence of antigens, such as proteins or glycoproteins, or the detection of the specific antibodies synthesized by the host organism against that particular pathogen.